Video: Lundbeck Scores a "3-Peat" with Third Straight Corporate Reputation Ranking

For the third straight year, Lundbeck US was ranked first in corporate reputation by U.S. patient groups. According to the new PatientView Corporate Reputation of Pharma, US Edition, Lundbeck also received top ranking in 10 individual reputational categories, including patient-centered strategy and acting with integrity. Read the press release to learn more about the rankings and watch the video below to hear more about our unique approach to patient advocacy.


When Corporate Reputation Gets Personal
By Peter Anastasiou
The new global PatientView Corporate Reputation of Pharma survey results are out, and Lundbeck received the highest net promoter score (NPS) of all companies included. Peter Anastasiou, Executive Vice President and Head of North America, writes about why this measure is so meaningful.
3 Insights From Lundbeck's Patient-Focused Approach to Business
By Staffan Schüberg
Lundbeck's Global Chief Commercial Officer shares three insights on driving a patient-focused approach to business.